Latest Industry Insights
Broadening the Adoption of Pharmacogenomic Testing
Technology Networks recently had the pleasure of speaking to Dr. Philip Empey, to learn more about the Pharmacogenomics Center for Excellence and how it is working to prove the clinical utility of predictive PGx testing.
Machine Learning Helps Achieve Greater Depth in Proteome Analysis
To understand how machine learning methods and new software capabilities are helping proteomics researchers gain greater depth in their analyses, Technology Networks recently interviewed Tharan Srikumar, product manager in bioinformatics at Bruker Daltonics.
A Paradigm Shift in Sepsis Diagnostics
In this interview, Rolland Carlson, PhD, CEO of Immunexpress, discusses sepsis and the company’s FDA cleared SeptiCyte® RAPID test, as well as a take on the company’s differentiated value and outlook.
Unlocking the Functional Antibody Repertoire
Technology Networks learns about serum epitope repertoire analysis and some of the applications it could benefit, including cancer diagnostics and COVID-19 studies.
How Can Wastewater Testing Predict COVID-19 Outbreaks?
Technology Networks spoke to Francisco Bizouarn, market development manager of the Digital Biology Group at Bio-Rad Laboratories, to find out how wastewater testing works and how it can anticipate a rise in cases of COVID-19 and the emergence of new variants.
Seeing Clearly Again: Using the Tear Lipidome To Detect Dry Eye After Laser Surgery
In this interview, Lei Zhou, PhD, head of the Ocular Proteomics Platform at the Singapore Eye Research Institute, talks about the development of a novel diagnostic test to guide precision medicine to prevent dry eye in patients after laser eye surgery.
Probing the Proteome With Engineered Nanoparticles
In this interview, Dr. Daniel Hornburg discusses how engineered nanoparticles could help to bridge the gap between proteomics and genomics and transform cancer diagnostics.
Identifying Risk Factors for Long COVID With Single-Cell Proteomics
In this interview we speak to Sean Mackay, CEO of IsoPlexis, to discuss how single-cell functional proteomics have helped researchers understand the risk factors behind long COVID.
When We Become Leaders, How Do We Lead Science Towards Gender Equity?
Emulate's chief scientific officer, Dr. Lorna Ewart, talks about inspiring a new generation of women in STEM.
A Landscape Assessment of Newborn Screening in Europe
This industry insight explores the findings from a comparative analysis of specific policies governing periodic updates to NBS panels in 30 European countries.